Pipeline endovascular device for the treatment of intracranial aneurysms at the level of the circle of Willis and beyond: multicenter experience

Martínez‐Galdámez, Mario; Romance, A.; Vega, Pedro; Vega, A.; Caniego, José Luis; Paúl, Laura; Linfante, Italo; Dabus, Guilherme

doi:10.1136/neurintsurg-2014-011355

Cited by 53 publications

(31 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These short-term studies were the only controls for 71.6% of all patients followed up and must surely have contributed to the low occlusion rates. A Spanish–American multicenter study showed that 6 months after treatment of bifurcation aneurysms using FDs, occlusion rates were as low as 64% 10. Yavuz et al 8 emphasized in their series that after 1–3 months a decrease in aneurysm diameter can be expected, whereas complete occlusion begins at about 6 months and might take up to 18 months.…”

Section: Discussionmentioning

confidence: 99%

Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries

Gawlitza

Januel

Tall

et al. 2015

J NeuroIntervent Surg

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries

Gawlitza

Januel

Tall

et al. 2015

J NeuroIntervent Surg

View full text Add to dashboard Cite

show abstract

“…In 2014, Martínez-Galdámez et al14 published a multicenter study of 25 patients of distal aneurysms treated with the Pipeline embolization device. They reported three technical complications with no clinical consequences: one acute branch occlusion resolved after increasing arterial pressure; one slow opacification of the inferior trunk of the MCA which resolved with an intrarterial reopro; and one focal subarachnoid hemorrhage secondary to distal perforation with the microwire during an exchange maneuver.…”

Section: Discussionmentioning

confidence: 99%

Periprocedural safety and technical outcomes of the new Silk Vista Baby flow diverter for the treatment of intracranial aneurysms: results from a multicenter experience

Martínez‐Galdámez

Biondi

Kalousek

et al. 2019

J NeuroIntervent Surg

View full text Add to dashboard Cite

PurposeThe aim of our study was to assess the technical success and the safety of this new low-profile flow diverter Silk Vista Baby (SVB) by evaluating the intraprocedural and periprocedural complication rate.Material/methodsClinical, procedural, and angiographic data were analyzed.Results: 41 consecutive patients (28 women; age average 50.5 years) with 43 aneurysms were treated with SVB. Aneurysm sizes were classified by their maximum diameter, with an average size of 9.5 mm (range 2–30 mm). Thirty-four cases were unruptured. five aneurysms previously ruptured, had recurrence after the initial coiling. There were two ruptured cases. Aneurysms' locations were: M1 segment (five cases), M2 segment (three cases), M3 segment (one case), middle cerebral artery (MCA) bifurcation (six cases), carotid-T (two cases), anterior communicating artery/A1/A2 (11 cases), pericallosal artery (four cases), supraclinoid ICA (two cases), PCom (one case), V4 segment (three cases), PCA (three cases), SCA (one case), and PICA (one case). We had five intraprocedural complications which resolved without clinical consequences and three events postprocedural events. Initial occlusion rates were: eight aneurysms (18.6%) were completely occluded, five aneurysms (11.6%) showed near-complete occlusion, four cases (9.3%) showed incomplete filling, and 26 cases (60.4%) showed persisting filling. The mRS score at discharge from the hospital did not change from the admission mRS score.ConclusionOur study demonstrated that the use of the new low-profile flow diverter, SVB device, for the treatment of intracranial aneurysms is feasible and technically safe.

show abstract

“…Martínez-Galdámez et al also looked at the use of PED to treat 25 aneurysms beyond the circle of Willis. 49 Their series had a complete occlusion rate of 64%, and the remaining 36% had significantly reduced residual filling. When evaluating side branches that were covered by PED placement, 79% were found to be patent at follow-up.…”

mentioning

confidence: 99%

Off-label uses of the Pipeline embolization device: a review of the literature

Patel

Chalouhi

Atallah

et al. 2017

Neurosurgical Focus

141

View full text Add to dashboard Cite

The Pipeline embolization device (PED) is the most widely used flow diverter in endovascular neurosurgery. In 2011, the device received FDA approval for the treatment of large and giant aneurysms in the internal carotid artery extending from the petrous to the superior hypophyseal segments. However, as popularity of the device grew and neurosurgeons gained more experience, its use has extended to several other indications. Some of these off-label uses include previously treated aneurysms, acutely ruptured aneurysms, small aneurysms, distal circulation aneurysms, posterior circulation aneurysms, fusiform aneurysms, dissecting aneurysms, pseudoaneurysms, and even carotid-cavernous fistulas. The authors present a literature review of the safety and efficacy of the PED in these off-label uses.

show abstract

Pipeline endovascular device for the treatment of intracranial aneurysms at the level of the circle of Willis and beyond: multicenter experience

Cited by 53 publications

References 15 publications

Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries

Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: a single-center series with special emphasis on covered cortical branches and perforating arteries

Periprocedural safety and technical outcomes of the new Silk Vista Baby flow diverter for the treatment of intracranial aneurysms: results from a multicenter experience

Off-label uses of the Pipeline embolization device: a review of the literature

Contact Info

Product

Resources

About